Macquarie Group Portfolio holdings
AUM
$81.5B
1-Year Return
21.2%
This Quarter Return
+8.17%
1 Year Return
+21.2%
3 Year Return
+85%
5 Year Return
+166.7%
10 Year Return
+339.95%
AUM
$70B
AUM Growth
+$10.4B
(+17%)
Cap. Flow
+$6.44B
Cap. Flow
% of AUM
9.19%
Top 10 Holdings %
Top 10 Hldgs %
14.72%
Holding
2,009
New
110
Increased
834
Reduced
584
Closed
91
Top Buys
| 1 |
Occidental Petroleum
OXY
|
+$176M |
| 2 |
DuPont de Nemours
DD
|
+$154M |
| 3 |
MRO
Marathon Oil Corporation
MRO
|
+$138M |
| 4 |
Cisco
CSCO
|
+$132M |
| 5 |
Edison International
EIX
|
+$130M |
Top Sells
| 1 |
Liberty Global Class C
LBTYK
|
+$104M |
| 2 |
Biogen
BIIB
|
+$78.9M |
| 3 |
TripAdvisor
TRIP
|
+$58M |
| 4 |
KKR & Co
KKR
|
+$47.4M |
| 5 |
Five Below
FIVE
|
+$45.7M |
Sector Composition
| 1 | Healthcare | 16.57% |
| 2 | Financials | 15.71% |
| 3 | Technology | 12.95% |
| 4 | Industrials | 9.06% |
| 5 | Consumer Staples | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYNH
826
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $4.21M | 0.01% |
70,762
+5,786
| +9% | +$344K |
|
827
Grupo Cibest S.A. American Depositary Shares (each representing four (4) Preferred Shares)
CIB
$12.6B
| $4.2M | 0.01% |
76,638
+4,458
| +6% | +$244K |
|
828
Rio Tinto
RIO
$102B
| $4.16M | 0.01% |
70,015
+4,072
| +6% | +$242K |
|
829
SPDR Gold MiniShares Trust
GLDM
$19.8B
| $4.15M | 0.01% |
+136,893
| New | +$4.15M |
|
830
AstraZeneca
AZN
$252B
| $4.14M | 0.01% |
82,952
-1,771
| -2% | -$88.3K |
|
831
SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$2.73B
| $4.12M | 0.01% |
+139,780
| New | +$4.12M |
|
832
Halozyme
HALO
$9.01B
| $4.08M | 0.01% |
230,000
| – | – |
|
|
AMED
833
DELISTED
Amedisys
AMED
| $4.07M | 0.01% |
24,386
+9,582
| +65% | +$1.6M |
|
|
SVC
834
Service Properties Trust
SVC
$484M
| $4.01M | 0.01% |
164,911
-26,264
| -14% | -$639K |
|
835
Tencent Music
TME
$39.6B
| $4.01M | 0.01% |
341,134
+50,900
| +18% | +$598K |
|
|
NXRT
836
NexPoint Residential Trust
NXRT
$869M
| $3.99M | 0.01% |
88,637
+33,837
| +62% | +$1.52M |
|
837
Genpact
G
$7.54B
| $3.93M | 0.01% |
93,088
+12,063
| +15% | +$509K |
|
838
Bloomin' Brands
BLMN
$591M
| $3.92M | 0.01% |
177,810
| – | – |
|
839
Globant
GLOB
$2.57B
| $3.91M | 0.01% |
36,861
-19,624
| -35% | -$2.08M |
|
840
W.P. Carey
WPC
$15B
| $3.91M | 0.01% |
49,824
-21,340
| -30% | -$1.67M |
|
841
LKQ Corp
LKQ
$8.46B
| $3.87M | 0.01% |
108,517
+2,637
| +2% | +$94.1K |
|
842
Norfolk Southern
NSC
$61.3B
| $3.87M | 0.01% |
19,924
-1,373
| -6% | -$266K |
|
843
GE Aerospace
GE
$299B
| $3.87M | 0.01% |
69,503
+19,805
| +40% | +$1.1M |
|
|
844
TripAdvisor
TRIP
$2.09B
| $3.84M | 0.01% |
126,498
-1,909,291
| -94% | -$58M |
|
845
Caesars Entertainment
CZR
$5.41B
| $3.82M | 0.01% |
64,032
-5,122
| -7% | -$305K |
|
846
Allogene Therapeutics
ALLO
$255M
| $3.81M | 0.01% |
146,779
| – | – |
|
847
SPX Corp
SPXC
$9.42B
| $3.79M | 0.01% |
74,502
-4,325
| -5% | -$220K |
|
848
Myriad Genetics
MYGN
$702M
| $3.77M | 0.01% |
138,300
-3,400
| -2% | -$92.6K |
|
|
CLLS
849
Cellectis
CLLS
$295M
| $3.76M | 0.01% |
219,675
| – | – |
|
850
SBA Communications
SBAC
$21.3B
| $3.76M | 0.01% |
15,600
-1,100
| -7% | -$265K |
|